StockVS

American Vanguard Corporation (AVD) स्टॉक विश्लेषण

मूल सामग्री

American Vanguard Corporation

$2.65

$-0.16 (-5.69%)

अंतिम अपडेट: 26 मई 2026

प्राइस हिस्ट्री

विश्लेषण

कंपनी का अवलोकन

American Vanguard Corporation engages in the development, manufacturing, and marketing of synthetic, biological, and biorational products designed for agricultural, commercial, and consumer applications across domestic and international markets. The enterprise operates within the Basic Materials sector, specifically focusing on the Agricultural Inputs industry, which involves the production of essential substances required for crop cultivation and soil management. The company maintains a workforce of 739 employees and holds a total market capitalization of $68.21 million, supported by an annual revenue stream of $515.11 million. These financial dimensions indicate that American Vanguard functions as a mid-sized entity within its niche, where the revenue figure suggests a significant operational footprint relative to its relatively modest market valuation. The disparity between the substantial revenue of $515.11 million and the market cap of $68.21 million implies that the market values the company's future cash generation potential differently than its current asset base, reflecting specific concerns regarding profitability or growth prospects in the agricultural inputs landscape.

वित्तीय स्वास्थ्य

The company reported a trailing twelve-month revenue of $515.11 million, while the net income for the same period stands at -$49,882,000, and the EBITDA is recorded at $22.80 million. The substantial gap between the positive revenue of $515.11 million and the significant negative net income of -$49,882,000 reveals a cost structure where operating expenses, including taxes and interest, far exceed the gross profits generated from sales. The free cash flow is -$4,736,875, indicating that the company is currently consuming cash rather than generating it, which limits its immediate financial flexibility for capital expenditures or organic expansion without external financing. In terms of profitability margins, the gross margin is 28.6%, while the operating margin is 3.5%, and the profit margin is -9.7%, signaling that after covering all operational costs, the company is operating at a loss on a per-revenue basis. The balance sheet shows a cash position of $12.43 million against total debt of $191.39 million, resulting in a debt-to-equity ratio of 99.47, which characterizes the balance sheet as highly leveraged rather than conservative. Despite the high leverage, the current ratio stands at 1.77, suggesting that the company possesses sufficient current assets to cover its short-term liabilities and maintain basic liquidity for at least the next twelve months. Return on Equity is -23.4% and Return on Assets is 0.4%, metrics that indicate management has struggled to generate positive returns on the shareholders' capital and the total asset base during this reporting period.

मूल्यांकन आकलन

The trailing P/E ratio is listed as N/A due to the negative net income, whereas the forward P/E is 6.13, implying that the market expects earnings to turn positive or improve significantly in the coming twelve months to justify the current stock price. The price-to-book ratio is 0.36, indicating that the stock is trading at a significant discount to its book value, which often reflects market skepticism about the quality of assets or the ability of management to generate value from them. Alternative valuation metrics such as the price-to-sales ratio of 0.13 and the EV/EBITDA of 10.84 suggest that the company is priced very low relative to its sales volume and enterprise value, potentially signaling undervaluation or deep-seated concerns about future cash flows. The 52-week high is $5.92 and the 52-week low is $2.05; without the current live price, the specific trading position relative to this range cannot be calculated, but the range demonstrates a wide trading band of $3.87 over the past year. The beta value is 1.43, meaning the stock price is expected to be 43% more volatile than the broader market, reflecting the cyclical nature of the agricultural inputs sector and the company's sensitivity to macroeconomic shifts.

Growth & Income

The revenue growth year-over-year is -9.0%, while earnings growth is N/A due to the recent losses, implying that the company is currently contracting in terms of sales volume rather than expanding its top line. Since the company is not a dividend payer, the dividend yield is N/A and the payout ratio is 0.0%, which means the company retains all its earnings, albeit currently negative, rather than distributing income to shareholders. The absence of dividend payments aligns with the company's financial reality of negative free cash flow and negative net income, necessitating a strategy of reinvesting available resources to stabilize operations rather than rewarding investors with cash distributions. The overall growth and income profile for American Vanguard Corporation is characterized by a decline in revenue, a lack of current profitability, and a total absence of dividend income, highlighting a company in a transitional or distressed financial phase within the agricultural inputs industry.

समकक्ष तुलना

American Vanguard Corporation (AVD) कृषि आदान उद्योग में कार्यरत है। बाजार पूंजीकरण के आधार पर इसके निकटतम समकक्षों से तुलना इस प्रकार है:

कंपनी टिकर मार्केट कैप P/E अनुपात
American Vanguard Corporation AVD $75.81M N/A
Corteva, Inc. CTVA $52.90B 42.8
Nutrien Ltd. NTR.TO $46.50B 14.3
Nutrien Ltd. NTR $33.66B 14.3

कृषि आदान उद्योग का औसत P/E अनुपात 37.5x है। American Vanguard Corporation का P/E अनुपात N/A है।

यह विश्लेषण AI द्वारा केवल सूचनात्मक उद्देश्यों के लिए तैयार किया गया है और यह वित्तीय सलाह नहीं है। डेटा में देरी या अशुद्धि हो सकती है। निवेश निर्णय लेने से पहले हमेशा अपना शोध करें और किसी योग्य वित्तीय सलाहकार से परामर्श लें।

American Vanguard Corporation के बारे में

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.

कंपनी विवरण अंग्रेजी में दिखाया गया है।

वेबसाइट देखें →

मुख्य आंकड़े

मार्केट कैप
$75.81M
P/E अनुपात
N/A
52 सप्ताह उच्च
$5.92
52 सप्ताह निम्न
$2.05
औसत वॉल्यूम
358.40K
बीटा
1.49

डेटा yfinance के माध्यम से Yahoo Finance द्वारा प्रदान किया गया है। दैनिक अपडेट।

कंपनी जानकारी

उद्योग
कृषि आदान
एक्सचेंज
NYSE
देश
United States
कर्मचारी
739